Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
The latest announcement is out from Achieve Life Sciences Inc (ACHV).
Achieve Life Sciences, Inc. has initiated a Registered Direct Offering and concurrent Private Placement to sell over 13 million shares and warrants, aiming to raise approximately $56.2 million in net proceeds. These funds are earmarked for the clinical development of cytisinicline, including the ORCA-OL clinical trial, and other corporate purposes. The offering is supported by a shelf registration statement and prospectus, with additional potential proceeds of $64.2 million if all Private Placement Warrants are exercised, potentially funding the company’s operations into 2026.
See more data about ACHV stock on TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue